Literature DB >> 28848012

In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives.

Gholam Reza Shokoohi1, Hamid Badali2, Hossein Mirhendi3, Saham Ansari4, Ali Rezaei-Matehkolaei5, Bahram Ahmadi6, Afsane Vaezi2,7, Mohamed Mahdi Alshahni8, Koichi Makimura8.   

Abstract

The in vitro activities of novel azoles compared to those of five antifungal drugs against clinical (n = 28) and environmental (n = 102) isolates of black mold and melanized yeast were determined. Luliconazole and lanoconazole had the lowest geometric mean MICs, followed by efinaconazole, against tested isolates compared to the other drugs. Therefore, it appears that these new imidazole and triazole drugs are promising candidates for the treatment of infections due to melanized fungi and their relatives.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  MIC; efinaconazole; in vitro; lanoconazole; luliconazole; melanized fungi

Mesh：

Substances：

Year:  2017        PMID： 28848012      PMCID： PMC5655049          DOI： 10.1128/AAC.00635-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Efinaconazole (Jublia) for the treatment of onychomycosis.

Authors:  Aditya K Gupta; Fiona C Simpson
Journal:  Expert Rev Anti Infect Ther       Date:  2014-05-22       Impact factor: 5.091

2.  In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.

Authors:  Y Tatsumi; M Yokoo; T Arika; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses.

Authors:  Hiroyasu Koga; Yuri Tsuji; Kazuyoshi Inoue; Kazuo Kanai; Toshiro Majima; Tatsuya Kasai; Katsuhisa Uchida; Hideyo Yamaguchi
Journal:  J Infect Chemother       Date:  2006-06       Impact factor: 2.211

Review 4.  Black Molds and Melanized Yeasts Pathogenic to Humans.

Authors:  Anuradha Chowdhary; John Perfect; G Sybren de Hoog
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

Review 5.  Dematiaceous Molds.

Authors:  Eunice H Wong; Sanjay G Revankar
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

6.  Mechanism of action of efinaconazole, a novel triazole antifungal agent.

Authors:  Yoshiyuki Tatsumi; Maria Nagashima; Toshiyuki Shibanushi; Atsushi Iwata; Yumi Kangawa; Fumie Inui; William J Jo Siu; Radhakrishnan Pillai; Yayoi Nishiyama
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

7.  In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent.

Authors:  Katsuhisa Uchida; Yayoi Nishiyama; Hideyo Yamaguchi
Journal:  J Infect Chemother       Date:  2004-08       Impact factor: 2.211

8.  In vitro antifungal activities of luliconazole, a new topical imidazole.

Authors:  Hiroyasu Koga; Yasuko Nanjoh; Koichi Makimura; Ryoji Tsuboi
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

9.  In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.

Authors:  Nesa Baghi; Tahereh Shokohi; Hamid Badali; Koichi Makimura; Ali Rezaei-Matehkolaei; Maryam Abdollahi; Mojtaba Didehdar; Iman Haghani; Mahdi Abastabar
Journal:  Med Mycol       Date:  2016-04-26       Impact factor: 4.076

Review 10.  Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Jianping Xu; Jacques F Meis
Journal:  PLoS Pathog       Date:  2013-10-24       Impact factor: 6.823
View more
  7 in total

1.  Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species.

Authors:  Mahdi Abastabar; Abdullah M S Al-Hatmi; Mohammad Vafaei Moghaddam; G Sybren de Hoog; Iman Haghani; Seyed Reza Aghili; Tahereh Shokohi; Mohammad Taghi Hedayati; Roshanak Daie Ghazvini; Reza Kachuei; Ali Rezaei-Matehkolaei; Koichi Makimura; Jacques F Meis; Hamid Badali
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

2.  In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates.

Authors:  Ali Rezaei-Matehkolaei; Sadegh Khodavaisy; Mohamad Mahdi Alshahni; Takashi Tamura; Kazuo Satoh; Mahdi Abastabar; Gholam Reza Shokoohi; Bahram Ahmadi; Mohammad Kord; Simin Taghipour; Koichi Makimura; Hamid Badali
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

3.  Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.

Authors:  Maral Gharaghani; Simin Taghipour; Ali Zarei Mahmoudabadi
Journal:  Mol Biol Rep       Date:  2020-11-01       Impact factor: 2.316

4.  Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates.

Authors:  Zahra Taheri Rizi; Mahdi Abastabar; Hamed Fakhim; Macit Ilkit; Fatemeh Ahangarkani; Javad Javidnia; Iman Haghani; Jacques F Meis; Hamid Badali
Journal:  Mycopathologia       Date:  2020-02-28       Impact factor: 2.574

5.  The high efficacy of luliconazole against environmental and otomycosis Aspergillus flavus strains.

Authors:  Maryam Moslem; Ali Zarei Mahmoudabadi
Journal:  Iran J Microbiol       Date:  2020-04

6.  Prediction of itraconazole minimum inhibitory concentration for Fonsecaea pedrosoi using Fourier Transform Infrared Spectroscopy (FTIR) and chemometrics.

Authors:  Alessandra Koehler; Valeriano Antonio Corbellini; Daiane Heidrich; Maria Lúcia Scroferneker
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

7.  Isolation and molecular characterization of clinical and environmental dematiaceous fungi and relatives from Iran.

Authors:  Gholamreza Shokoohi; Hamid Badali; Bahram Ahmadi; Kazuo Satoh; Sadegh Nouripour-Sisakht; Mahnaz Nikaeen; Mohsen Gramishoar; Nilufar Jalalizand; Sahar Kianipour; Hossein Mirhendi; Koichi Makimura
Journal:  Curr Med Mycol       Date:  2021-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.